Navana Pharma

Navana Pharma

Navana Pharma posts 50% profit growth in H1

Navana Pharma posts 50% profit growth in H1

Higher sales, improved margins and stronger cash flows drive earnings and boost share price

Navana Pharma forays into herbal medicine sector with Tk21cr investment

Navana Pharma forays into herbal medicine sector with Tk21cr investment

Navana Pharma to invest Tk145cr in new production unit

Navana Pharma to invest Tk145cr in new production unit

Navana Pharma allowed to issue Tk150cr bond

Navana Pharma allowed to issue Tk150cr bond

Navana Pharma posts record revenue, profit amid higher costs

Navana Pharma posts record revenue, profit amid higher costs

Navana Pharma to convert 60% of Tk150cr bond into shares

Navana Pharma to convert 60% of Tk150cr bond into shares

Navana Pharma to renovate plant instead of setting up new one

Navana Pharma to renovate plant instead of setting up new one

Navana Pharma to issue Tk150cr bond for loan repayment

Navana Pharma to issue Tk150cr bond for loan repayment

Navana Pharma posts 54% higher profit in March quarter

Navana Pharma posts 54% higher profit in March quarter

Photo: Collected

Navana Pharma’s profit grows 16% in Jul-Dec

How Navana Pharma made profit even in crisis

How Navana Pharma made profit even in crisis

Photo: Collected

Navana Pharma IPO subscription opens on 13 September

Photo: Collected

Navana Pharma share cut-off price set at Tk34